Molecular Infectious Disease Testing Market Size, Share, Trends, Growth Outlook, and Opportunities to 2034- By Products and Services (Reagents & Kits, Instruments, Services & Software), By Type (Multiplex Testing, Singleplex Testing), By Test Type (Laboratory Tests, Point Of Care Tests), By Disease (Respiratory Infectious Diseases, Gastrointestinal Infectious Diseases, Sexually Transmitted Diseases, Hospital-Acquired Infections, Vaginitis, Meningitis, Vector-Borne Diseases, Others), By Technology (Polymerase Chain Reaction, Isothermal Nucleic Acid Amplification Technology, DNA Sequencing & Next-Generation Sequencing, In Situ Hybridization, DNA Microarrays, Others), By End-User (Diagnostic Laboratories, Hospitals & Clinics, Others), Countries and Companies Report
The Global Molecular Infectious Disease Testing Market Size is estimated at $10.3 Billion in 2025 and is forecast to register an annual growth rate (CAGR) of 12.8% to reach $30.5 Billion by 2034.